| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.25 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |